home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login »

Iroko Pharmaceuticals

Undisclosed

Specialty Pharmaceuticals
Pain

Iroko is a global specialty pharmaceutical company, based in Philadelphia, dedicated to advancing the science of analgesia. The company develops and globally commercializes pharmaceutical products. Iroko is at the forefront of the development of SoluMatrix® NSAIDs – new low dose drug products based on existing NSAIDs – using iCeutica Inc.’s proprietary SoluMatrix Fine Particle Technology™ exclusively licensed to Iroko for NSAIDs. VIVLODEX is the third SoluMatrix®NSAID and is available in pharmacies; VIVLODEX is approved by FDA.